AKBA
AKBA
NASDAQ · Biotechnology

Akebia Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$1.12
+0.02 (+1.82%)
As of Jun 24, 3:06 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target +3,243.8% upside
Low Target $22.27
Average Target $37.45
High Target $46.32
Current Price $1.12
Current
$1.12
Target
$37.45
$22.27 $37.45 avg $46.32
Scenario Analysis
Bear Case
$22.27
1,888.4%
Low target
Base Case
$37.45
+3,243.8%
Avg target
Bull Case
$46.32
+4,035.7%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$4.08
-72.5% from high
52-Week Low
$0.82
+36.1% from low
50-Day SMA
$1.26
-11.1% vs SMA
RSI (14)
38.1
Neutral
Target vs 52W High
$37.45
+818.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.7%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +189.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -7.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -65.2%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.8%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -45.0%